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ABSTRACT
HmtDB (http://www.hmtdb.uniba.it:8080/hmdb) is a
open resource created to support population
genetics and mitochondrial disease studies. The
database hosts human mitochondrial genome se-
quences annotated with population and variability
data, the latter being estimated through the applica-
tion of the SiteVar software based on site-specific
nucleotide and amino acid variability calculations.
The annotations are manually curated thus adding
value to the quality of the information provided to
the end-user. Classifier tools implemented in
HmtDB allow the prediction of the haplogroup for
any human mitochondrial genome currently stored
in HmtDB or externally submitted de novo by an
end-user. Haplogroup definition is based on the
Phylotree system. End-users accessing HmtDB are
hence allowed to (i) browse the database through
the use of a multi-criterion ‘query’ system; (ii) ana-
lyze their own human mitochondrial sequences via
the ‘classify’ tool (for complete genomes) or by
downloading the ‘fragment-classifier’ tool (for
partial sequences); (iii) download multi-alignments
with reference genomes as well as variability data.
INTRODUCTION
In the last decades, population and evolutionary genetics
have run towards a deeper and deeper survey of human
genetic variation, thanks to the use of an ever-increasing
spectrum of markers. Such knowledge has represented
a turning point in the study of the evolutionary forces
that shaped human diversity, enabling the reconstruction
of human populations’ history and representing an ex-
tremely precious chance to explore the genetic basis of
adaptation and its crucial medical implications. In this
scenario, mitochondrial DNA (mtDNA) has played a
pivotal role both because the mitochondrion is highly
involved in a great number of cellular processes in
health and disease, and because of its consolidated use
as phylogenetic marker. Human mtDNA is a polyploid
molecule 16570bp long on average. The number of
copies of the mitochondrial genome ranges from a few
hundreds to 200000 molecules per cell, depending upon
the cytotype. However, also due to an inefﬁcient repair
system, mutations are more easily ﬁxated with respect to
those in nuclear DNA, giving rise to the phenomenon of
heteroplasmy, namely the coexistence within a cell of dif-
ferent mtDNA genotypes. In evolutionary terms, on
average, the mtDNA of two unrelated individuals may
differ by 50nt (1). Such highly polymorphic nature has
allowed to cluster human mtDNAs into haplogroups,
each containing a subset of mtDNAs sharing ﬁxed muta-
tions acquired from the same ancestral DNA (2). Hence,
various population lineages may be described by means of
a phylogenetic tree in which the top nodes deﬁne
haplogroups and the tips haplotypes. Major haplogroups
are ethno-speciﬁc, and their classiﬁcation is becoming in-
creasingly ﬁner thanks to the growth in the type and
quantity of available molecular data. Indeed, a large
amount of sequence variation data and related informa-
tion deriving from mitochondrial population genetics and
clinical studies are continuously produced and processed.
Population studies and reconstruction of phylogeny have
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segments 1 and 2 (HVS1 and HVS2 regions), two frag-
ments of the mtDNA genome of about 300bp located
within the D-loop, the major mtDNA regulatory region.
In addition, the recognition of polymorphisms along the
entire coding part of the genome has been mainly en-
trusted on data obtained from restriction fragment-length
polymorphism techniques; these data, added to the
variants observed in the two HVS regions, have
contributed to the ﬁrst haplogroups deﬁnition. Clinical
deﬁnition of ‘mitochondrial pathologies’ indicating very
severe or mild forms of neuromuscular disorders has
been based on the screening of speciﬁc mutations of
mtDNA which often may have variable penetrance and
expressivity. Starting from 2001 (3), the sequencing of the
entire human mitochondrial genome has become an
ever-increasing compulsory approach both with the aim
to study human populations and to understand whether
and how mtDNA mutations impinge on disease features,
in penetrance and expressivity. This trend is currently
growing thanks to the advent of next-generation
sequencing (NGS) technologies. The extent of the appli-
cation of large-scale mtDNA sequencing is evident when
searching GenBank for human complete mitochondrial
genomes. In a short lapse of time, the number of whole
human mtDNA sequences deposited has risen to 8700
(updated in June 2011). These sequences carry with them
a large amount of information speciﬁcally associated to
individuals belonging to the most various populations of
the globe. These individuals may be healthy or may
present disease-associated phenotypes, such as a
clear-cut adult and pediatric neuro-muscular disease or
diabetes or the most prevalent age-associated
neurodegenerative diseases, i.e. Parkinson’s (4)o r
Alzheimer’s (5) and even various cancer phenotypes (6,7).
The comparison of each mtDNA complete sequence
with the revised Cambridge Reference Sequence (rCRS,
GenBank Accession NC_012920.1) (8,9) allows to
identify variant sites and hence to assign the most appro-
priate haplogroup. Moreover, the occurrence of
individual-speciﬁc, or private, mutations may lead either
to deﬁne a new sub-haplogroup or to highlight association
with disease. The worldwide recognized reference system
that gathers these data into a complete and updated
human mtDNA haplogroup classiﬁcation tree is
Phylotree [(10), http://www.phylotree.org].
Whenanewgenomeissequenced,itsannotationmustbe
basedonpreviouslyﬁlteredinformation,generallycollected
within human mtDNA-speciﬁc resources. The starting
website is usually MITOMAP, a compendium of poly-
morphisms and mutations of human mtDNA (11). Indeed,
each published human mtDNA polymorphism or disease
associated mutation is annotated in tables, where the
mutation is associated to the publication reference. The
search engine does not allow combining multiple searching
criteria.Nofrequencydataconcerningmutationsandpoly-
morphisms are available. The complete human mtDNA se-
quences can be downloaded by GenBank through a link to
Entrez (NCBI). With respect to the human mtDNA
haplogroups a simpliﬁed tree image can be downloaded.
Links to the other worldwide mitochondrial resources are
implemented. A comparison between them and the
resource here presented, HmtDB, is detailed in the
‘Discussion’section.
Here we report an updating of HmtDB, a mtDNA
genomic resource previously described (12) where
complete human mitochondrial genomes are annotated
with information derived from primary databases and lit-
erature manually curated; moreover information concern-
ing variability obtained by the application of speciﬁc
software are stored.
HmtDB Organization
The core of HmtDB is the database, which reports all
publicly available human mitochondrial genomes
obtained from healthy or pathologic samples. Within the
healthy category are the genomes derived from population
studies, whereas the pathologic category hosts genomes of
subjects affected with classical mitochondrial as well as
any other disease in which mitochondrial alterations
have been suspected to play a role.
The genomes from both data sets are further classiﬁed
in ﬁve sub-data sets, one for each continent. The genomes
extracted from the International Nucleotide Sequence
Database Collaboration (INSDC) primary databases
(13), are subjected to a characterizing protocol (described
in the ‘HmtDB database generation and updating’
section). The obtained results are annotated in HmtDB
with other information such as the human mtDNA
haplogroup classiﬁcation obtained by the elaboration of
the entire Phylotree classiﬁcation and any other data con-
cerning disease associated mutations as reported in
MITOMAP. The updating of the haplogroup classiﬁca-
tion is synchronized with that of Phylotree. The HmtDB
database is of relational type, designed and implemented
using the DB2 Relational Database Management System
(DBMS) from IBM corporation. HmtDB structure details
have been previously reported (12).
Upon accessing HmtDB (www.hmtdb.uniba.it:8080/
hmdb) a web page introduces the user to the description
of the resource via the sidebar links. A click on access to
HmtDB displays a menu which allows to visualize the
macrofunctions that may be activated within the
resource: Query HmtDB, Classify your genome,
Fragment Classify and HmtDB downloading. The menu
macrofunctions Query and Classify are also listed on the
top bar, which remains accessible at any stage of the
HmtDB consulting session.
HmtDB database generation and updating
The exponential growth of whole mtDNA genomes
generated by the implementation of large-scale sequencing
has led to an optimization of the HmtDB updating pro-
cedure in order to keep up with data posted in INSDC. A
central role in the HmtDB database is assumed by the
haplogroup classiﬁcation data derived from Phylotree.
Being HmtDB a network available in html format and
frequently updated, we have implemented a semi-
automatic protocol which, starting from the ‘html’
Phylotree document extracts the new data and updates
‘excel’ tables which are further elaborated and stored in
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tral nodes which are simply annotated with the rCRS
position. In order to facilitate and assure a most precise
transformation of the Phylotree structure in a ﬁle which is
part of the HmtDB data and which can be correctly used
for the haplogroup predictions, we have assigned to the
nodes without name, a name according to rules which can
be also useful to the user to understand how deep a
genome classiﬁcation can be reached. Supplementary ﬁle
1 reports the list of the nodes positions and of the codes we
have assigned. Here below the HmtDB updating
ﬂow-chart is described and the complete updating
workﬂow is reported in Figure 1.
Extraction of new genomes from GenBank. A MyNCBI
account has been activated, whose function is to
automatically check for newly deposited human mito-
chondrial genomes stored in GenBank, on a monthly
basis. When new sequences become available, data
download is manually performed. The Entrez query per-
formed is: ‘(014000[SLEN]:017000[SLEN]) AND ‘‘Homo
sapiens’’[Organism] AND mitochondrion AND yy/mm/
dd:yy/mm/dd [publication date] NOT NC_012920.1’.
The SLEN ﬁlter allows the selection of both complete
and partial genomes. The two dates allow to extract
from GenBank those genomes that have been published
subsequently to the last HmtDB update. The accession
number list of the newly downloaded genomes is then
compared with the previous version contained in
HmtDB to verify whether the genome is already present.
If this is the case, the updated genomes are overwritten in
HmtDB. The new genomes are hence handled according
the procedure below.
Annotation of the new genomes. New genomes are down-
loaded both in GenBank and FASTA format. Data avail-
able in the GenBank entry and in the associated literature
are in part extracted through the application of the Python
script ‘parse_entry.py’ and in part by curators, which care-
fully read both the GenBank entry and the associated lit-
erature. The information gathered is ﬁnally stored in the
‘HmtDB Genome Annotation Excel Table’.
HmtDB Genomes Multi-Alignment. Both healthy and
pathologic genome sets have been thus far multi-aligned
by applying the MAFFT program (14). Recently, due to
the increasing number of sequences, a strategy has been
implemented to facilitate a one-shot multi-alignment
(MA) of thousands of genomes. Such method considers
the assumption that human mtDNA sequence variation is
prevalently based on single nucleotide polymorphisms.
Hence, MA software may generate ambiguous alignments
only around homopolymeric regions where short inser-
tions/deletions (indels) are frequently observed. Thus, in
order to avoid the random insertion of gaps in the auto-
matically generated MA, a set of rules has been ﬁxed for
each homopolymeric stretch. Table 1 reports for each
rCRS region where the rules have been ﬁxed an extract
of the rCRS multi-aligned sequence in the region as it is in
the whole healthy dataset MA. The criteria are decided
and implemented by taking into account the haplogroup
deﬁning positions located in the considered region accord-
ing to data reported in Phylotree. The whole MA process
is performed via the Seaview Editor; new genomes are
Figure 1. The HmtDB database generation workﬂow. The workﬂow
describes the procedure implemented when updating HmtDB.
Table 1. Description of the rules implemented for the updating of the
genomes MA
Range positions in rCRS Aligned rCRS range sequence
302–318
513–526
564–574
955–966
2141–2151
3565–3572
5894–5902
16179–16194
D1152 Nucleic AcidsResearch, 2012,Vol. 40,Database issueadded directly to the previously existing MA and
manually re-aligned. The resulting MA is stored and sub-
sequently processed with the SiteVar software. Moreover,
continent-speciﬁc MAs are automatically produced, as an
extract of both healthy and pathologic all data set
genomes. The user may ﬁnally download any MAs
through the HmtDB downloading function. Based on
the multi-aligned sequences, for each genome the SNPs
table, including also the insertion and deletion events, is
produced.
Application of ‘SiteVar’ Algorithms. Human mtDNA is a
small molecule, 16570nt long, with only a small part of
which being non-coding. It is therefore highly constrained
in the maintenance of its functions. Notwithstanding this
and because no exhaustive repair systems are active within
mitochondria (15), mutation rate is 10 times higher than
that of nuclear DNA (16). Thus, the availability in a single
resource of such a large number of human mitochondrial
genomes from subjects representative of worldwide popu-
lations is a unique occasion to estimate through a rigorous
analysis which sites are more prone to mutate and how
frequently each mutation occurs. HmtDB allows the esti-
mation of both nucleotide and amino acid site variability
via the SiteVar (17) and the MitVarProt (18) programs.
Details about the software are available in Supplementary
File 2. The variability values range from 0 to 1. Sites
whose variability value is close to 1 present an allele
whose state is common to an entire sub-tree of the
whole tree representative of the genomes stored in
HmtDB or could be subjected to recurrent mutations.
Low variability values may be suggestive of a novel
haplogroup-deﬁning variant or indicate a rare
disease-linked mutation.
Storage of new genomes and related data in the DB2
HmtDB database. Once the genomes and their related in-
formation have been retrieved and variability estimated,
the so-called batch process is launched, allowing the
storage of data in the HmtDB database. An identiﬁer is
assigned to each annotated genome according to the
format ZZ_YY_####, where ZZ is the continent code
(AF for Africa, AS for Asia, AM for America, EU for
Europe and OC for Oceania), YY is the two-letter code
corresponding to the country from which the subject ori-
ginates, #### is a four digit code sequentially assigned for
each newly added genome. When the continent and/or the
country are unknown ZZ=XX and YY=XX. For patho-
logic genomes the ID format is PA_YY_####.
The HmtDB macrofunctions
Query HmtDB. The query function allows the user to
retrieve data from HmtDB. The retrieval is performed ac-
cording to an advanced search system carried out through
the Boolean combination of different criteria correspond-
ing to the ﬁelds deﬁned in the design of the database.
Figure 2 reports the query form as it is available on
the web site. Table 2 summarizes the whole set of
criteria. The retrieval output displays a list brieﬂy
describing the retrieved genomes: HmtDB Identiﬁer,
Database source Identiﬁer and Pubmed brief description
of the paper where the genome has been published. With a
click on the Database source identiﬁer as well as on the
PubMed ID, the GenBank entry and the reference
abstract are displayed, respectively. A click on the
HmtDB Identiﬁer displays the genome card. Multiple
genomes may be browsed at once by selecting them
through the left square and then by clicking on view
genome cards displayed on the bottom of the page.
Figure 3 shows an example of an HmtDB stored
genome card. The MAs as well as the sequences of the
selected genomes can be downloaded. When downloading
MAs data, both the download of the rCRS sequence and
the use of the SeaView (20) MA editor are suggested.
Classify your genome. The release of more than 8000
human mtDNAs has implicated an expansion of the
haplogroup tree and boosted the need of a set of tools
to allow haplogroup assignment. Phylotree (10) is an ex-
cellent system that allows the user to have a complete
overview of the most updated haplogroup classiﬁcation.
However, the haplogroup attribution based on Phylotree
can only be performed manually. HmtDB automatically
attributes the haplogroup through the classify procedure
which includes the Phylotree structure. This procedure is
performed individually on every genome stored in
HmtDB, and it also runs through the classify your
genome macrofunction. It essentially consists of automat-
ic comparison between a single human mitochondrial
genome (query) and the rCRS sequence, with the aim of
detecting the pattern of mtDNA SNPs of the query. The
haplogroup prediction for the HmtDB annotated genome
is based on the SNPs table. In the classify your genome
option, the comparison is based on the application of the
MUSCLE software (21). Upon matching of an obtained
pattern against the Phylotree haplogroup classiﬁcation
stored in HmtDB, the prediction of the query sequence
haplogroup may be performed. A genome card of the
submitted genome is generated and displayed, on which
the haplogroup prediction is expressed as a list of
haplogroups for which a match was found, and, for each
haplogroup, a percentage of the detected variations with
respect to the total number of variations deﬁning the
haplogroup is given (Figure 3). The genome cards
produced after the application of the query and classify
macro functions have similar formats, although the latter
lacks information concerning the genome source and ref-
erences. In the genome card information about the
uniqueness of the haplotype genome within HmtDB is
shown.
Fragment classify tool. Although sequencing of the entire
mitochondrial genome is becoming a feasible approach,
frequently researchers prefer to focus on short fragments
of the genome, especially in disease case studies. In these
circumstances, due to the scattering of the deﬁning sites of
any speciﬁc haplogroup along the entire mtDNA mol-
ecules, the sensibility of the above-described classiﬁcation
tool becomes increasingly lower as the length of the
fragment decreases. The fragment-haplo-classiﬁer tool
has been designed to overcome this problem. For each
haplogroup it selects, among the total number of SNPs
Nucleic Acids Research, 2012,Vol. 40,Database issue D1153Figure 2. The HmtDB ‘query’ form. A detailed description of the implemented retrieval criteria is reported in Table 2.
Table 2. List and descriptions of criteria that may be combined when using the HmtDB retrieval system (Query macro function)
Query criteria Description
HmtDB Genome Identiﬁer A pop up menu allows to select a genome whose HmtDB genome identiﬁer is known.
Reference DB ID A pop up menu allows to select a genome whose INSDC Accession number is known.
Subject’s geographical origin (continent/country) A pop up menu allows to select genomes whose associated subject belong to a speciﬁc con-
tinent/country.
Author/Fragment_Classiﬁer Haplogroup user code A pop up menu allows to select genomes matching with a speciﬁc haplogroup as it has
been assigned in the associated paper and for partial genomes as it has been assigned by
the fragment classiﬁer tool.
Complete genomes / Only coding region HmtDB annotates complete genomes or genomes not inclusive of the D-loop region.
SNP position Position of the rCRS sequence reporting in the genomes to be selected a mutation respect
to rCRS.
Variation type It is possible to add to the position search, the option to search for genomes whose asked
position reports transition or trasversions only, and in addition to search for a speciﬁc
transition or transversion. Within Variation type it is possible to ask to search for
Genomes reporting Insertion and/or deletions in assigned positions.
Subject age Genomes whose related subjects had a speciﬁc age at the sampling time.
Subject sex Genomes from subjects of a speciﬁc gender.
DNA source Genomes sequenced from sample extracted from a speciﬁc tissue.
Individual type Genomes from healthy or pathologic data sets or from a phenotype related to a speciﬁc
disease.
References Genomes related to a speciﬁc paper or to paper published from a speciﬁc author, or a
genome identiﬁed in the paper with a speciﬁc haplotype code.
The Haplogroup user code may not match with the haplogroup predicted by the application of the classiﬁer tool because this last is assigned
according to the last updating of Phylotree while the ﬁrst one was assigned when the genome was published.
D1154 Nucleic AcidsResearch, 2012,Vol. 40,Database issueFigure 3. The genome card associated to the genome AF_BF_0004. The genome card is organized in three parts hosting the following annotations.
(Part 1) Data allowing the genome identiﬁcation (HmtDB identiﬁer, genome accession number and database of origin, the Author/
Fragment_classiﬁer Predicted Haplogroup code, the haplotype identiﬁer, the tissue origin of DNA, the length of the genome, the sequencing
technique and the Pubmed link to the reference where the genome has been published) followed by the haplogroup prediction as described in
Nucleic Acids Research, 2012,Vol. 40,Database issue D1155
(continued)located in the fragment region, the ones annotated in
Phylotree (Nph). Furthermore, the tool reports the
number of SNPs deﬁning the haplogroup in the whole
genome (Nph_tot) and the Nph_tot subset expected in the
fragment Nph_exp. The assigned haplogroup is the one
whose fraction of Nph over the total number of the
haplogroup-deﬁning expected sites (Nph_exp) is highest.
The higher is the ratio Nph_exp/Nph_tot, the more robust is
the assignment. The number of Nph sites deﬁning the
haplogroups is strictly related to the evolutionary
distance between rCRS and the considered genomes.
Hence, higher is the distance lower will be the reliability
of the obtained prediction as much as shorter is the
fragment. Since partial genomes are also annotated in
HmtDB, the Author/Fragment_Classiﬁer Predicted
Haplogroup code has been introduced within the
Genome Card (Figure 3) in order to correct the
haplogroup prediction, which may not be obtained with
the entire genome classiﬁer. Next to the haplogroup
assigned by the author, the best haplogroup prediction
upon application of the fragment classiﬁer is indicated.
Supplementary File 3 reports the results obtained by
applying the fragment classiﬁer tool to 820 partial
genomes from healthy subjects available in HmtDB.
The tool is written in Python and it can be downloaded
as a package to be locally implemented. Instructions about
the use of the package (Supplementary File 4) are avail-
able as documentation ﬁle when clicking on the fragment
classiﬁer option.
HmtDB downloading. The downloading function allows
to download (i) MAs of the entire healthy and pathologic
as well as of the continent speciﬁc data sets; (ii) variability
data obtained by applying SiteVar software.
The HmtDB database content
HmtDB contains human mitochondrial genomes derived
from the public primary INSDC databases. Genomes
associated to population studies are stored and analyzed
as a whole data set (healthy) and grouped in
continent-speciﬁc subsets (AF: Africa, AM: America,
AS: Asia, EU: Europe, OC: Oceania). Genomes from
subjects affected by diseases are reported in a separate
data set annotated as pathologic. The number of items
of each data set is available through the Statistics
window (Figure 4). Data reported here refer to the last
download from GenBank (19 June 2011). The application
of the BlastClust program on each continent speciﬁc
subset both from healthy and pathologic data sets has
allowed to determine the number of unique haplotypes
for each group (Table 3). The analysis was performed ac-
cording to the following command line: ‘blastclust -i inﬁle
-o outﬁle -p F -L1 -b T –S100’. BlastClust (written by
I.Dondoshansky in collaboration with Y.Wolf) is avail-
able from NCBI via ftp (ftp://ftp.ncbi.nlm.nih.gov/blast)
and works only with stand-alone BLAST.
The BlastClust manual reports that the parameters we
have ﬁxed in the run are those to be chosen are the con-
ditions to be chosen to clusterize together only identical
sequences: thus two genomes with even a single mismatch
are here ﬂagged as belonging to different haplotypes. A
less stringent analysis may be implemented, although it is
difﬁcult to ﬁx a threshold that may allow to recognize true
from false different haplotypes in connection with
sequencing quality. The choice to use stringent
BlastClust parameters, instead, allows with a good ap-
proximation to estimate human mtDNA variability
based on the number of different haplotypes observed.
DISCUSSION
In the present article, we report an updating of the
HmtDB genomic resource (8), a database intended to
support both population geneticists as well as clinicians
undertaking the task to assess the pathogenicity of speciﬁc
mtDNA mutations. The major improvements here
reported concern the query system and the classiﬁer
tools. The increasing number of complete and fragmented
human mitochondrial genomes published requires the
availability of updated and well-structured resources to
give access in real time to the new data produced. In
this context the Phylotree web system, integrated with
HmtDB, represents a valid support to this aim, making
the haplogroup prediction of newly produced genomes
as well as of genomes previously published ﬁne and
reliable. Indeed, once new genomes are sequenced, the
browsing of the database and the application of the clas-
siﬁers become pivotal procedures in order to verify the
quality of the sequence. In fact, in the attempt to attribute
the haplogroup to the submitted genome, the classify tool
provides information that may attribute an inappropriate
haplogroup. The reason for this may reside in the mis-
reading of the sequence. In light of the many cases of mis-
interpretation due to nuclear mitochondrial sequences
(NumtS) contamination, phantom mutations and recom-
bination artifacts, as brought up by Refs (22–25), it is
plausible to wonder whether the increase in number of
human mitochondrial genomes relevantly contributes to
foster knowledge or merely to augment noise (22). A
critical examination of the classify results may highlight
Figure 3. Continued
the classify your genome section and based on Phylotree classiﬁcation (the percentage threshold is ﬁxed to 75); a click on the haplogroup code opens
a new window where the haplogroup deﬁning sites are displayed in association with Yes or No ﬂag indicating whether the genome harbours the allele
that contributes to the haplogroup deﬁnition. (Part 2) Data about the individual from which the DNA has been extracted. (Part 3) Variability table:
each line in the table refers to a mutation; the colour of the line is associated to the locus type (see colour legend when connected to HmtDB). The
line reports mutation data (nucleotide and, when appropriate, amino acidic positions, alleles and locus name), the mtREV index (19) indicating the
amino acidic change probability estimated on mammalian mitochondria-coded proteins, the variability index estimated on the two nucleotide data
sets and on the corresponding amino acidic data sets as well as on proteins derived from 60 mammalian genomes. Finally, data derived from
MITOMAP concerning the association to the disease are reported. On the bottom of the genome-card data concerning deletion and insertion events
are shown. A clicking on the variability index opens up a new window, reporting more detailed data concerning the site variability in different
continents and in pathologic samples.
D1156 Nucleic AcidsResearch, 2012,Vol. 40,Database issuethe absence/presence of some alleles which could un-
equivocally allow the attribution of the genome to an ap-
propriate haplogroup. This aspect strengthens the value
of HmtDB in the application of the classiﬁer tools both in
the case of the complete genome as well as in the case of
fragments. However, in the latter circumstance, the
reliability of the predicted haplogroup depends upon the
length as well as the region of the genome where the frag-
ment maps. Indeed, the haplogroup deﬁning sites are
spread along the genome albeit not in a homogeneous
fashion. Thus, one of our main goals is to identify the
most informative regions on the basis of the Phylotree
data. However, the application of the fragment classiﬁer
tool has demonstrated to be a powerful tool when applied
to the HmtDB partial genomes (Supplementary File 3).
Such application has allowed to update the haplogroup
assignment taking into account the more detailed actual
classiﬁcation as well as to revise incorrect attribution.
Examples of human mtDNA data revised upon the
direct implementation of HmtDB tools are abundant in
the recent literature (6,7,26,27). The query system helps
researchers to easily retrieve data on variants not listed in
other databases (e.g. MITOMAP), when pathogenic po-
tential of mtDNA variants need to be predicted. Also, the
availability of site variability data contributes both to the
deﬁnition of new haplogroups and to the recognition of
private variants or mutations with a potential pathogenic
role. It is worth mentioning that with respect to amino
acid changes, the estimation of the functional effect
obtained with external systems such as PolyPhen
Figure 4. The Statistics window. For each data set and sub-data sets the number of HmtDB stored genomes and of their variant sites is summarized.
Table 3. HmtDB haplotypes
Continent Data set Genomes (n) Unique haplotypes (n) Unique haplotypes (%)
Africa Healthy 826 772 93.46
Pathologic 0 0 0.00
America Healthy 693 656 94.66
Pathologic 4 4 100.00
Asia Healthy 3185 3171 99.56
Pathologic 501 465 92.81
Europe Healthy 1597 1527 95.62
Pathologic 237 230 97.05
Oceania Healthy 193 184 95.34
Pathologic 0 0 0.00
All continents Healthy 6494 6310 97.17
Pathologic 742 699 94.20
Unique haplotypes number and percentage in the healthy and pathologic continent data sets. All continents number of genomes does not match with
the whole ‘healthy’ data set quantity of genomes because of the unclassiﬁed_continent genomes.
Nucleic Acids Research, 2012,Vol. 40,Database issue D1157(28), or SIFT (29) may further contribute to evaluate the
quality of the sequence as well as the impact on the
phenotype. However, disease-associated mutations are
not only located in protein coding loci. Various mutations
have been described as responsible for or associated with
disease, which map within RNA genes (both tRNAs and
rRNAs). In these cases, the observation of the effect on
the secondary structure as well as the comparison of the
site variability within the inter-vertebrata MA ought to be
compulsory validating procedures in order to estimate
pathogenicity.
Furthermore, both quality and correct interpretation of
collected data is of utmost importance to this purpose. In
clinical studies, HmtDB may represent an advanced tool
towards a further development of tailored databases
including all relevant data related to genotype, phenotype,
family history, healthy controls and functional studies to
allow a more accurate interpretation for clinicians and
their patients. To start developing this ambitious task,
the ﬁrst issue we intend to tackle concerns the individual
type annotation. In this context, the clear distinction
between healthy and pathologic categories of the data
adds an important value to the database. Genomes are
in fact separated in the two categories based on what is
reported in the paper where they are extracted from.
Nonetheless, deﬁnition of pathologic with respect to
healthy may be ambiguous as the latter adjective may be
used to indicate that the subject does not show the path-
ology for which he/she is used as control, which usually
occurs in case–control studies. Within HmtDB, the patho-
logic subset indicates that the sequence comes either from
a pathologic somatic tissue or from the blood of affected
individuals, whom in many cases may have been screened
following a suspect or a diagnosis of a mitochondrial
disease. In cases when the mtDNA is sequenced from a
pathologic somatic tissue, it is worth to underline that
such sequences may not be necessarily different from the
constitutive mtDNA, unless they harbor proven somatic
mutations. Similarly, sequences obtained from constitu-
tive mtDNA of pathologic individuals may not always
harbor germ-line mutations. With respect to the healthy
category, it must be said that it includes all mtDNAs for
which the health status of the subject is not speciﬁed, a
common feature for genomes extracted from
population-based studies. These genomes may not be ne-
cessarily devoid of private or pathologic mutations,
although the fact that they have been mostly sequenced
from blood (or saliva) renders this condition very likely.
Ultimately, there is still a need for a more punctual anno-
tation. Lack of speciﬁcations as well as the plethora of yet
uncovered mitochondria-related pathologic conditions
makes it virtually impossible to correctly classify
mtDNAs within the two above-mentioned categories,
with the exception of few certain cases. Nevertheless,
this division is thus far, in our opinion, the most function-
al when it comes to choose a population of controls, which
however should be carefully selected based on the variabil-
ity data HmtDB reports.
HmtDB is not the only resource where data concerning
human mtDNA variability are stored. Starting from the
MITOMAP home page, links to the most relevant
databases are implemented. Nonetheless, upon accessing
some of these resources, it becomes evident that they are
no longer updated, whereas others host data conﬁned to
the HVS1 and HVS2 regions only. Only MitoTool (30)
presents aspects which overlap with the features imple-
mented in HmtDB. All the others are either incomplete
or provide complementary information, such as Zaramit
(31), Phylotree (10), EMPOP (32) and MITOMAP (11).
The combined use of all these resources, integrated with
HmtDB, have the potential to offer the scientiﬁc commu-
nity a true human ‘mitochondriome’ portal.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Files 1–4.
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